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Abstract: Background: The aim is to correlate pulmonary arterial (PA) remodeling estimated by PA fibrosis in PA 
hypertension (PAH) with clinical follow-up. Histology of PA specimens is also performed. 
Methods: 19 patients, aged 54±16 (4 men), functional class II-III were studied with right heart catheterization, PA 
Intravascular Ultrasound and optical coherence tomography (OCT) in inferior lobe segment. PA wall fibrosis was 
obtained by OCT ( area of fibrosis/PA cross sectional area  100). Patients follow-up was blind to OCT. Events were 
defined as mortality, lung transplantation, need of intravenous prostaglandins or onset of right ventricular failure. 
Results: OCT measurements showed high intra- and interobserver agreement. There was a good correlation between OCT 
and histology in PA fibrosis from explanted lungs. Area of fibrosis was 1.4±0.8 mm
2
, % fibrosis was 22.3±8. Follow-up 
was 3.5 years (2.5-4.5). OCT %Fib was significantly correlated with PA capacitance (r=-0.536) and with pulmonary 
vascular rsistance (r=0.55). Patients were divided according to the median value of PA fibrosis. There were 10 patients 
with a high (  22%) and 9 with a low fibrosis (<22%). Events occurred in 6 (1 death, 1 lung transplantation, 2 intravenous 
prostaglandins, 2 right heart failure) out of 10 patients with high and in 0 out of 9 patients with low fibrosis (p<0.01). 
Conclusions: In PAH, the severity of PA remodeling assessed by OCT wall fibrosis was significantly predictive of 
severely unfavorable clinical outcome. In vivo assessment of pulmonary arterial wall fibrosis by intravascular OCT in 
PAH is a promising new prognostic marker of adverse clinical outcome. 
Keywords: Catheterization, pulmonary heart disease, prognosis, remodeling. 
INTRODUCTION 
 Pulmonary arterial hypertension (PAH) is a rare and 
severe condition characterized by vascular proliferation and 
remodeling of the small pulmonary arterial wall. The 
histological findings in PAH include intimal hyperplasia, 
medial hypertrophy and adventitial proliferation/fibrosis. 
Currently the risk-to-benefit ratio of open lung tissue biopsy 
in PAH is unfavorable. However, intimal thickening by  
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fibrosis appears to predict shorter survival from the time of 
biopsy [1,2]. 
 Palevsky et al. showed that an intimal area of more than 
18% of the vascular cross-sectional area had an 85% 
predictive value for identifying poor outcome [3]. 
 Therefore, accurate detection and quantification of 
intimal fibrosis would be important in the assessment of PA 
remodeling and disease prognosis. 
 In addition, the histological remodelling process of the 
arterial wall has been characterized by narrowing and 
stiffening. Pulmonary arterial stiffening, which can occur 
both proximal and distal PAs, has gained increasing 
recognition due to its significant contribution to RV afterload 
and clinical relevance in PAH [4-6]. 
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 Remarkable advances in the different vascular imaging 
techniques such as computed magnetic resonance, 
intravascular ultrasound (IVUS) or optical coherence 
tomography (OCT) provide an opportunity to gain insight 
into the histopathology that could previously only be 
obtained through open lung biopsy. 
 Intravascular Ultrasound (IVUS) has been validated as a 
reliable method for describing pulmonary vessel wall 
morphology [4,7,8]. 
 Optical Coherence Tomography (OCT) is a new high-
resolution imaging modality that has proven its superiority 
over IVUS for characterization of coronary atherosclerotic 
plaque [9,10]. 
 OCT utilizes a near infrared light source (1300 nm of 
wavelength) in combination with advanced fiber-optics to 
create a dataset of the artery wall. The use of infrared light 
allows for a ten-fold higher image resolution but at the 
expense of a reduced penetration depth (2-3 vs 4-8 mm) [11]. 
According to our knowledge, there is scarce and poorly 
analyzed literature on the use of OCT in PAH [12,13]. 
 The objective of this study is to investigate the ability 
and accuracy of OCT to detect and quantify intimal fibrosis, 
as a marker of histological remodeling of the pulmonary 
arterial wall in patients with PAH, and to analyze its relation 
to right ventricular afterload and clinical prognosis. 
METHODS 
Study Population 
 Nineteen consecutive patients with stable (no change in 
clinical status or medication in the last 6 months) PAH 
attending the Pulmonary Hypertension Unit outpatient clinic 
of our hospital were recruited for undergoing cardiac 
catheterization at our institution (January 2007 - September 
2008). The only exclusion criteria were refusal to participate 
in the study or having PAH in functional class IV. The study 
had been approved by the institutional ethics committee, and 
a written informed consent had been obtained from every 
patient. Basal clinical and hemodymanic characteristics are 
shown in Table 1. 
 The patients were aged 25-81 years, in functional class 2-
3, with no clinical and pharmacological changes in the last 4-
6 months. The diagnosis of PAH was made according to the 
standard algorithm including a right heart catheterization. All 
patients were treated according to current guidelines.( 3 on 
bosentan, 10 on sildfenafil, 4 on bosentan and sildenafil, 1 
on bosentan, sildenafil and epoprostenol, and 1 on bosentan, 
sildenafil and iloprost ). 
Hemodynamic and IVUS Assessments 
 Right heart catheterization is part of the routine follow-
up of these patients at our institution. IVUS and OCT were 
performed for the purposes of the study. All patients 
underwent right heart catheterization in supine position and 
breathing room air. A 7 F Swan-Ganz catheter (Edwards 
Lifesciences, USA) was inserted into a brachial vein and a 5 
F end-hole catheter was inserted into the right radial artery. 
Catheters were connected to fluid-filled transducers and 
zeroed at the atmospheric pressure. Right atrial pressure, 
pulmonary arterial pressure (PAP), pulmonary arterial 
occlusion pressure (PAOP) and systemic arterial pressure 
were measured. Cardiac output and cardiac index were 
obtained from the Fick method and assumed basal oxygen 
consumption. Pulmonary vascular resistance index (PVRI) 
was calculated as mean arterial pulmonary pressure minus 
PAOP/cardiac output x body surface area. Pulmonary 




Table 1. Hemodynamic, IVUS and OCT Data 
 
Female, n (%) 15 (79) 
Age (years) 54 ± 16 
WHO, n (%)  
Class II 9 (47) 
Class III 10 (53) 
Diagnoses, n (%)  
IPAH 14 (74) 
PAH associated with collagen vascular disease 3 (16) 
PAH associated with HIV 2 (10) 
6MWT (m) 384 ± 99 
Mean PAP (mmHg) 46 ± 14 
Pulse PAP (mmHg) 44 ± 15 
PVRI (wood units.m2) 16.7 ± 7.4 
Cp (ml/mmHg) 1.33 ± 0.8 
CI (liters/min/m2) 2.2 ± 0.5 
SVI (ml/m2) 30 ± 9 
RAP (mmHg) 8 ± 3 
PAOP (mmHg) 9 ± 2 
Mixed VOS (%) 64 ± 7 
IVUSp (%) 23.6 ± 11 
Elastic Modulus (mmHg) 200 ± 85 
% Fibrosis (OCT) 22.3 ± 8 
Fibrosis Area (mm2) 1.4 ± 0.8 
Data are mean ± SD. CI: cardiac index; Cp: capacitance index; IVUSp: IVUS 
pulsatility; Mixed VOS: mixed venous oxygen saturation; PAOP: pressure arterial 
oclusion pressure; PAP: pulmonary arterial pressure; RAP: right atrial pressure. 
 
 IVUS was done with an Eagle Eye Gold catheter 20MHz, 
3.5F (Volcano Corporation, USA). Images were obtained 
from a segmental PA of the inferior lobe (elastic PA between 
2-3 mm) [15]. Diastolic and systolic cross-sectional areas of 
the studied segment were analyzed off-line by two observers 
unaware of clinical and hemodynamic findings. We 
estimated IVUS pulsatility as (systolic – diastolic lumen 
area/diastolic lumen area  100) and elastic modulus as 
(pulse pressure/pulsatility)
 
[4,15,16]. Intra- and interobserver 
validation of IVUS measurements in our laboratory had 
already been published [6]. 
Time Domain OCT Acquisition and Analysis 
 After hemodynamic and IVUS measurements, the OCT 
acquisition was performed using a commercially available 
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system for intracoronary imaging (LightLab Imaging, 
Westford MA, USA) [11]. 
 An Helios coaxial occlusion balloon catheter and a 
LightLab ImageWire (LightLab Imaging Inc, Westford MA, 
USA) was advanced over a 0,014” guidewire into the same 
pulmonary artery branch where the IVUS images were 
obtained, using an exchange guidewire system and X-ray 
control. This method guarantees that IVUS, OCT and PA 
pressure are obtained at the same level of the studied PA 
branch. Images were acquired during a pullback rate of 1.0 
mm/s. Occlusion and saline flush technique was used. PA 
flow is stopped by inflating the proximal occlusion balloon 
and flushing a crystalloid solution through the end-hole of 
the balloon catheter in order to run off blood and obtain high 
quality images. The size of the studied arteries was within 
the published penetration depth range of the OCT [17]. 
 According to the study from Yabushita et al. [18], 
fibrosis is represented by OCT as intimal thickening with a 
high reflectivity, low attenuation and homogenous signal. In 
the same image the inner lumen area and the area limited by 
the outer boundary of fibrosis are measured. Subtraction of 
these two areas represents fibrosis area. Percentage of 
fibrosis is calculated as the ratio between the fibrosis area / 
lumen cross-sectional area (%fibrosis). 
 Reproducibility of the OCT fibrosis area was assessed in 
a random sample of 10 PAH patients of the study 
population.. Bland-Altman analysis was performed to 
evaluate the intraobserver and interobserver agreement. The 
OCT measurements were repeated blindly a few days later 
by the same observer and by a second independent observer, 
on the same cross-sectional image of the OCT pullback. The 
results are expressed as intraclass correlation coefficient. 
Pathology Study 
 One pulmonary artery from a patient with PAH and one 
from a normal lung were studied with OCT and histology. 
The arteries were dissected from two explanted lungs, one 
from a patient with PAH receiving pulmonary 
transplantation and the other from a patient with healthy 
lungs who died from another cause. Two 4 cm-long arterial 
segments were sent for OCT imaging. After the OCT study, 
the arteries were sectioned every 2 mm, embedded in 
paraffin, sectioned with the microtome at 5 m and stained 
with Hematoxylin-Eosin and Masson Trichrome for wall 
fibrosis assessment. OCT imaging was performed with the 
same OCT imaging catheter with the pulmonary artery 
submerged in saline. Automatic pull-back at a constant speed 
was performed along the length of the artery and used to 
calculate the precise location of the studied PA segment. 
OCT and histological images were thus obtained from the 
same PA section. 
Clinical Follow-Up 
 Patients were prospectively followed up every six 
months. No patients were lost to follow-up. Physicians who 
carried out the follow-up were blind to the IVUS and OCT 
results. Prior to analysis, patients had been divided into 2 
groups, low and high degree of fibrosis, according to the 
median value of PA wall OCT fibrosis percentage. 
 
 The outcome was clinical deterioration, that had been 
initially defined in terms of either mortality, lung 
transplantation, need of intravenous prostaglandins or onset 
of clinical right ventricular failure. 
Statistical Analysis 
 Both measured and calculated data were expressed as 
mean±standard deviation. Data analysis was carried out with 
SPSS 17.0 for Windows. All subjects were included in the 
analysis. Results were considered significant if p  0.05. 
Student’s t-test for independent samples was used to evaluate 
differences between groups; chi-squared was used for 
analyzing categorical variables (proportions), and Pearson’s 
test for correlations. Bland-Altman analysis was used to 
evaluate inter- and intraobserver agreement. The Kaplan-
Meier method was used to obtain survival curves. 
RESULTS 
Hemodynamics, OCT and IVUS in PAH Patients 
 Table 1 shows clinical data and mean values for 
hemodynamic, IVUS and OCT variables of all patients. A 
typical OCT image of a PA in a patient with pulmonary 
arterial hypertension is shown in Fig. (1). Measurements of 
both maximal and minimal areas showed a high intra and 
interobserver agreement. Intraclass intraobserver correlation 
coefficients were: 0.997 (CI95%: 0.989-0.999) and 0.999 
(CI95%:0.996-0.999) and the interclass interobserver 
correlation coefficients were: 0.998 (CI95%: 0.993-0.999) 
and 0.999 (CI95%:0.998-0.999) for maximal and minimal 
areas, respectively. 
 OCT percentage of fibrosis was better correlated with 
capacitance (r= -0.53; p=0.02) than with PVRI (r = 0.55; 
p=0.01) (Fig. 2). Neither IVUS pulsatility nor elastic 
modulus were correlated with OCT. After dividing the 
cohort of patients according to the median of elastic modulus 
(203 mmHg), no differences in percentage of fibrosis were 
found between high and low wall stiffness groups (21 ± 5 vs 
21 ± 9 %, NS). After dividing the cohort of patients 
according to the median of OCT fibrosis (22%), mean PAP 
and PVRI were higher (p < 0.05) and Cp was lower (p = 
0.07) in the patients with higher OCT fibrosis. However, no 
differences in IVUSp and EM were found between high and 
low PA fibrosis groups (25 ± 14 vs 27 ± 17 %; and 197 ± 
100 vs 194 ± 68 mmHg; respectively). 
OCT and Histological Fibrosis 
 Fig. (3) shows the excellent agreement between the 
assessment of PA wall fibrosis by OCT and histology in a 
patient without PH (no fibrosis) and in a patient with PAH 
(severe fibrosis). 
Clinical Follow-Up 
 All patients were prospectively followed up for 3.5 years 
(2.5-4.5 years). Patients were divided into 2 groups, low 
(16±4) and high (29±6%)degree of fibrosis, according to the 
median value of PA wall OCT fibrosis percentage (22%). 
Mean follow-up time was not significantly different between 
patients with severe or non-severe fibrosis. There were 10 
patients with a high degree of fibrosis (  22%) and 9 with a  
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    (a)          (b) 
  
Fig. (1). In vivo OCT image of a pulmonary artery in a patient with Pulmonary Arterial Hypertension (a). Calculation of the amount of 
fibrosis of the arterial wall (b). 
 
Fig. (2). Pearson correlations between pulmonary vascular resistance index (PVRI) (a) and PA capacitance (b) and % of fibrosis. Dot 
diagram of PVRI (c) and Cp (d) in all patients studied grouped according to % of fibrosis. 
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lower degree of fibrosis (<22%). Clinical deterioration, as 
previously defined, were present in 6 patients (1 death, 1 
lung transplantation, 2 intravenous prostaglandins, 2 right 
heart failure) out of 10 patients with severe fibrosis and in 0 
out of 9 patients with less fibrosis (p<0.01). In Kaplan-Meier 
analysis, mean time to event was markedly different between 
both groups of patients (Log-Rank test p=0.011) (Fig. 4). 
DISCUSSION 
 This is the first study to assess the ability of OCT for 
detecting and estimating PA fibrosis and to correlate it with 
RV afterload, PA wall stiffness and clinical prognosis in  
patients with stable PAH. OCT provides a high-quality 
morphological evaluation of the elastic pulmonary vessels of 
patients with pulmonary hypertension. The exploration is 
safe, and can be undertaken at the time of right heart cardiac 
catheterization with a high inter and intraobserver 
agreement. 
 The excellent agreement between OCT and histological 
fibrosis images in the explanted PA offer additional 
validation for using this new technique to quantify PA wall 
fibrosis (Fig. 3). 
 Patients with a higher degree of wall intimal fibrosis 
showed higher steady (PVRI increase) and pulsatile 
(capacitance decrease) components of PA afterload. 








Fig. (3). Cross-section of a medium-sized pulmonary artery from a patient without pulmonary hypertension showing a medium-sized 
pulmonary artery without hypertensive changes (Masson Trichrome, x 100) (a). OCT image of the same cross-section where no fibrosis is 
appreciated (b). Cross-section of a medium-sized pulmonary artery from a patient with pulmonary hypertension showing severe intimal 
fibrosis (Masson Tricrome, x 100) (c). OCT image of the same cross-section where the area of fibrosis has been marked ( area between green 
and yellow lines ) (d). 
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elastic modulus, the absence of correlation between 
structural (OCT fibrosis) and functional (IVUS elastic 
modulus) wall remodeling makes evident the complex 
interaction between the different PA wall components in the 
remodeling process. The increased elastic modulus not only 
depends on the extent of wall fibrosis. Vasoconstriction, 
transmural PA pressure and wall geometrical factors 
(thickness/radius ratio) also influence the elastic modulus. In 
addition, this cohort represents extremely ill patients with 
such a high degree of wall fibrosis that it does not allow the 
analysis of the relationship between fibrosis and elastic 
modulus throughout the whole continuum of the disease 
process [16,19-21]. 
 
Fig. (4). Event-free Kaplan-Meier survival curve for severe fibrosis 
(green) and non-severe fibrosis (blue) groups of patients showing a 
clinically relevant and significant difference. 
 Palevsky et al. [3]
 
showed that only the area of intimal 
fibrosis was significantly different between those patients 
who exhibited rapid deterioration and those PH who remain 
stable on follow-up. The mean area of intimal fibrosis was 
25.6 ± 15.8% for the group that worsened rapidly and 10 ± 
7.6% for stable patients, with 18% as cutoff point. This is in 
accordance with our data, since patients with severe fibrosis 
(  22%) presented more clinical events (including death and 
lung transplantation) than patients with less fibrosis (< 22%). 
 OCT only allows the assessment of capacitance vessels 
but not that of resistance vessels. Capacitance vessels are 
upstream from the resistance vessels evaluated using 
standard histopathologic criteria for disease severity. 
However the decrease in PA capacitance has been proven to 
be a strong predictor of mortality tn PAH [5]. 
 Therefore the in vivo histological analysis with OCT of 
the severity of wall fibrosis of capacitance PA may represent 
a novel approach to the study of the remodeling process in 
these arteries. Furthermore the severity of OCT wall fibrosis 
observed in our patients is clearly and significantly related to 
clinically relevant events during mid-term follow-up, which 
stresses the prognostic value of the assessment of 




 The pulmonary vascular illness is patchy rather than 
uniform throughout the lung. We estimated OCT fibrosis of 
PA elastic arteries of lower lobes since Bressollette et al. 
showed that lower lobes PA have greater wall thickness than 
in upper lobes [22]. 
 A limitation of OCT is its limited penetration depth, 
although the vessels imaged in this study (2-3 mm) are in the  
range of OCT performance [17,23,24]. Although, there is a 
good correlation between histological intimal fibrosis and 
OCT fibrosis, additional clinical-pathological correlation 
studies will be important to further define PA wall tissue 
characteristics by OCT assessments. 
 This study only analyzed 19 patients. Although this may 
be considered a small group, PAH is an infrequent disease 
and the number of studied patients was large enough to 
obtain a significant correlation between PA wall fibrosis and 
mid-term clinical follow-up. 
CONCLUSION 
 PA wall fibrosis assessed by OCT correlates with the 
severity of PA dynamic afterload. In PAH, the severity of 
PA remodeling assessed by quantification of PA wall 
fibrosis by OCT was significantly predictive of severely 
unfavorable clinical outcome. We suggest the usefulness of 
OCT as a novel diagnostic tool for evaluating PA structural 
wall remodeling in patients with PAH throughout the disease 
process, as a marker of prognosis and potential response to 
treatment [25]. 
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ABBREVIATIONS 
OCT = Optical coherence tomography 
IVUS = Intravascular ultrasound 
PA = Pulmonary artery 
PAH = Pulmonary arterial hypertension 
MWT = Minute walking test 
PVRI = Pulmonary vascular resistance index 
Cp = Pulmonary capacitance 
CI = Cardiac index 
SVI = Stroke volume index 
RAP = Right atrial pressure 
PAOP = Pulmonary artery occlusion pressure 
EM = Elastic modulus 
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